Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.23
0.00 (0.00%)
At close: Aug 20, 2025, 11:02 AM
Citius Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
PE Ratio | -0.48 | -0.38 | -1.19 | -3.36 | -3.72 | -7.99 | -5.43 | -4.56 | -9.07 | -6.77 | -13.39 | -9.22 | -6.36 | -14.46 | -10.16 | -24.89 | -34.15 | -17.27 | -2.9 |
PEG Ratio | 0.01 | 0.16 | -0.00 | -1.57 | -0.28 | 1.06 | 0.75 | -0.33 | 0.39 | -0.04 | 0.24 | 0.99 | -0.38 | 0.79 | -0.12 | 1.24 | 36.62 | 0.24 | -0.08 |
PS Ratio | n/a | n/a | n/a | 930.65 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.27 | 0.28 | 0.71 | 2.07 | 1.84 | 3.44 | 2.36 | 1.99 | 3.15 | 3.13 | 1.92 | 2.87 | 2.04 | 3.70 | 3.02 | 3.74 | 5.82 | 2.28 | 3.75 |
P/FCF Ratio | n/a | -3.8 | -9.81 | -24.54 | -18.81 | -35.07 | -32.66 | -26.65 | -32.09 | -36.32 | -39.9 | -46.54 | -29.05 | -45.08 | -80.57 | -10.83 | -164.68 | -66.68 | -9.88 |
P/OCF Ratio | n/a | -3.8 | -9.81 | -24.54 | -18.81 | -35.07 | -32.66 | -26.65 | -32.09 | -36.32 | -39.9 | -46.54 | -29.05 | -45.08 | -80.57 | -88.34 | -164.92 | -66.68 | -9.88 |
OCF/S Ratio | n/a | n/a | n/a | -37.92 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 |
Quick Ratio | 0.14 | 0.06 | 0.09 | 0.17 | 6.75 | 5.17 | 5.06 | 5.95 | 7.10 | 5.62 | 9.33 | 9.84 | 11.40 | 14.49 | 9.25 | 18.28 | 32.48 | 35.17 | 1.57 |
Current Ratio | 0.47 | 0.37 | 0.41 | 0.40 | 6.75 | 5.17 | 5.06 | 5.95 | 7.10 | 5.62 | 9.33 | 9.84 | 11.40 | 14.49 | 9.25 | 18.28 | 32.48 | 35.17 | 1.57 |
Asset Turnover | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.04K | -1.06K | -2.06K |
Return on Equity | -0.14 | -0.19 | -0.15 | -0.15 | -0.12 | -0.11 | -0.11 | -0.11 | -0.09 | -0.12 | -0.04 | -0.08 | -0.08 | -0.06 | -0.07 | -0.04 | -0.04 | -0.03 | -0.32 |
Return on Assets | -0.07 | -0.09 | -0.08 | -0.09 | -0.11 | -0.09 | -0.09 | -0.1 | -0.08 | -0.1 | -0.03 | -0.07 | -0.07 | -0.06 | -0.07 | -0.03 | -0.04 | -0.03 | -0.23 |
Return on Invested Capital | n/a | -0.16 | -0.14 | -0.14 | -0.12 | -0.13 | -0.1 | -0.1 | -0.08 | -0.11 | -0.07 | -0.07 | -0.08 | -0.06 | -0.07 | -0.04 | -0.04 | -0.03 | -0.25 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | -69.2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | -70.12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | -70.87 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | -70.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |